Delivery Order SPE2DB20D3101-SPE2DB23FRQB4
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 prescription medications to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,216.89 and an ultimate completion date of March 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made on March 6, 2024, and there is no set-aside designation....
- This federal contract award is for the delivery of Trelegy Ellipta, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,891.00 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,016.40, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The award has a performance period through February 12, 2024 and is a Firm Fixed Price Delivery Order contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, valued at $8,528.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of pharmaceutical products, specifically Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,825.32 and an ultimate completion date of October 22, 2021. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Trelegy Ellipta, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,346.04 and is a firm fixed-price delivery order, with a completion date of January 26, 2024. The contract was awarded on January 25, 2024, and there is no set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta pharmaceutical products, valued at $2,680.83. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This is a delivery order contract with a firm-fixed price pricing type. The contract has a completion date of June 18, 2024 and was...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,385.51 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 28, 2022 with a completion date of January 31, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $10,568.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 27, 2023 and was awarded on July 26, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRQB4Delivery Order
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,049.34 and an ultimate completion date of June 26, 2023. The contract is a Firm Fixed Price Delivery Order and was awarded on June 23, 2023. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/23/23 |